Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jan Cleerbout"'
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 2, Pp 109-121 (2017)
Safety and reactogenicity data were reviewed following 10 years of experience with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in clinical development and from post-licensure settings. Analyses
Externí odkaz:
https://doaj.org/article/830c7fbbd1e14512812f3ce5703d9a65
Autor:
James J, Sejvar, Katrin S, Kohl, Jane, Gidudu, Anthony, Amato, Nandini, Bakshi, Roger, Baxter, Dale R, Burwen, David R, Cornblath, Jan, Cleerbout, Kathryn M, Edwards, Ulrich, Heininger, Richard, Hughes, Najwa, Khuri-Bulos, Rudolf, Korinthenberg, Barbara J, Law, Ursula, Munro, Helena C, Maltezou, Patricia, Nell, James, Oleske, Robert, Sparks, Priscilla, Velentgas, Patricia, Vermeer, Max, Wiznitzer, Jan, Bonhoeffer
Publikováno v:
Vaccine. 29(3)
n/a
Autor:
Heinz-Josef Schmitt, Thomas Verstraeten, Lode Schuerman, Jeanne-Marie Jacquet, Fred Zepp, Jan Cleerbout
Publikováno v:
Expert review of vaccines. 8(6)
Combination vaccines that include multiple antigens within one formulation are now widely accepted as an effective means of eliciting protection against several diseases at the same time. Owing to improvements in quality and convenient modes of admin
Autor:
Bertrand Chevallier, Javier Arístegui, Patricia Lommel, Timo Vesikari, Nancy Bermal, Dorota Borys, Markus Knuf, Lode Schuerman, Jerzy Brzostek, Jan Cleerbout
Publikováno v:
The Pediatric infectious disease journal. 28
Background: Licensed pneumococcal conjugate vaccine (7vCRM) is usually coadministered with combination vaccines in pediatric immunization programs. Reactogenicity and safety after primary and booster vaccination with a novel 10-valent pneumococcal no